Literature DB >> 27898570

Are Centers for Disease Control and Prevention Guidelines for Preexposure Prophylaxis Specific Enough? Formulation of a Personalized HIV Risk Score for Pre-Exposure Prophylaxis Initiation.

Matthew R Beymer1, Robert E Weiss, Catherine A Sugar, Linda B Bourque, Gilbert C Gee, Donald E Morisky, Suzanne B Shu, Marjan Javanbakht, Robert K Bolan.   

Abstract

BACKGROUND: Preexposure prophylaxis (PrEP) has emerged as a human immunodeficiency virus (HIV) prevention tool for populations at highest risk for HIV infection. Current US Centers for Disease Control and Prevention (CDC) guidelines for identifying PrEP candidates may not be specific enough to identify gay, bisexual, and other men who have sex with men (MSM) at the highest risk for HIV infection. We created an HIV risk score for HIV-negative MSM based on Syndemics Theory to develop a more targeted criterion for assessing PrEP candidacy.
METHODS: Behavioral risk assessment and HIV testing data were analyzed for HIV-negative MSM attending the Los Angeles LGBT Center between January 2009 and June 2014 (n = 9481). Syndemics Theory informed the selection of variables for a multivariable Cox proportional hazards model. Estimated coefficients were summed to create an HIV risk score, and model fit was compared between our model and CDC guidelines using the Akaike Information Criterion and Bayesian Information Criterion.
RESULTS: Approximately 51% of MSM were above a cutpoint that we chose as an illustrative risk score to qualify for PrEP, identifying 75% of all seroconverting MSM. Our model demonstrated a better overall fit when compared with the CDC guidelines (Akaike Information Criterion Difference = 68) in addition to identifying a greater proportion of HIV infections.
CONCLUSIONS: Current CDC PrEP guidelines should be expanded to incorporate substance use, partner-level, and other Syndemic variables that have been shown to contribute to HIV acquisition. Deployment of such personalized algorithms may better hone PrEP criteria and allow providers and their patients to make a more informed decision prior to PrEP use.

Entities:  

Mesh:

Year:  2017        PMID: 27898570      PMCID: PMC5145736          DOI: 10.1097/OLQ.0000000000000535

Source DB:  PubMed          Journal:  Sex Transm Dis        ISSN: 0148-5717            Impact factor:   2.830


  20 in total

1.  Modeling the impact of social discrimination and financial hardship on the sexual risk of HIV among Latino and Black men who have sex with men.

Authors:  George Ayala; Trista Bingham; Junyeop Kim; Darrell P Wheeler; Gregorio A Millett
Journal:  Am J Public Health       Date:  2012-03-08       Impact factor: 9.308

Review 2.  Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors.

Authors:  F E Harrell; K L Lee; D B Mark
Journal:  Stat Med       Date:  1996-02-28       Impact factor: 2.373

3.  A method for checking regression models in survival analysis based on the risk score.

Authors:  J K Grønnesby; O Borgan
Journal:  Lifetime Data Anal       Date:  1996       Impact factor: 1.588

4.  Prediction of coronary heart disease using risk factor categories.

Authors:  P W Wilson; R B D'Agostino; D Levy; A M Belanger; H Silbershatz; W B Kannel
Journal:  Circulation       Date:  1998-05-12       Impact factor: 29.690

5.  A risk score for chronic kidney disease in the general population.

Authors:  Conall M O'Seaghdha; Asya Lyass; Joseph M Massaro; James B Meigs; Josef Coresh; Ralph B D'Agostino; Brad C Astor; Caroline S Fox
Journal:  Am J Med       Date:  2012-03       Impact factor: 4.965

Review 6.  AIDS and the health crisis of the U.S. urban poor; the perspective of critical medical anthropology.

Authors:  M Singer
Journal:  Soc Sci Med       Date:  1994-10       Impact factor: 4.634

7.  The cost-effectiveness of preexposure prophylaxis for HIV prevention in the United States in men who have sex with men.

Authors:  Jessie L Juusola; Margaret L Brandeau; Douglas K Owens; Eran Bendavid
Journal:  Ann Intern Med       Date:  2012-04-17       Impact factor: 25.391

8.  Associations of sexual identity or same-sex behaviors with history of childhood sexual abuse and HIV/STI risk in the United States.

Authors:  Thersa Sweet; Seth L Welles
Journal:  J Acquir Immune Defic Syndr       Date:  2012-04-01       Impact factor: 3.731

9.  Childhood sexual abuse is highly associated with HIV risk-taking behavior and infection among MSM in the EXPLORE Study.

Authors:  Matthew J Mimiaga; Elizabeth Noonan; Deborah Donnell; Steven A Safren; Karestan C Koenen; Steven Gortmaker; Conall O'Cleirigh; Margaret A Chesney; Thomas J Coates; Beryl A Koblin; Kenneth H Mayer
Journal:  J Acquir Immune Defic Syndr       Date:  2009-07-01       Impact factor: 3.731

10.  A syndemic of psychosocial problems places the MSM (men who have sex with men) population at greater risk of HIV infection.

Authors:  Wu Jie; Lu Ciyong; Deng Xueqing; Wang Hui; Hong Lingyao
Journal:  PLoS One       Date:  2012-03-30       Impact factor: 3.240

View more
  12 in total

1.  Decisional Balance and Contemplation Ladder to Support Interventions for HIV Pre-Exposure Prophylaxis Uptake and Persistence.

Authors:  Steven A John; H Jonathon Rendina; Tyrel J Starks; Christian Grov; Jeffrey T Parsons
Journal:  AIDS Patient Care STDS       Date:  2019-01-17       Impact factor: 5.078

2.  PrEP Eligibility and Interest Among Clinic- and Community-Recruited Young Black Women in Atlanta, Georgia, USA.

Authors:  J M Sales; R J Steiner; J L Brown; A Swartzendruber; A S Patel; A N Sheth
Journal:  Curr HIV Res       Date:  2018       Impact factor: 1.581

3.  Misclassification of sexual health risks in a self-identified low risk cohort of men who have sex with men (MSM) enrolled in a community based PrEP program.

Authors:  Kellie Freeborn; Carmen Portillo; Cherie B Boyer; Glen Milo Santos
Journal:  AIDS Care       Date:  2019-05-25

4.  Brief Report: Impact of PrEP Training for Family Planning Providers on HIV Prevention Counseling and Patient Interest in PrEP in Atlanta, Georgia.

Authors:  Jessica M Sales; Carrie Cwiak; Lisa B Haddad; Ashley Phillips; Leah Powell; Ilyssa Tamler; Anandi N Sheth
Journal:  J Acquir Immune Defic Syndr       Date:  2019-08-01       Impact factor: 3.731

5.  An Empiric Risk Score to Guide PrEP Targeting Among MSM in Coastal Kenya.

Authors:  Elizabeth Wahome; Alexander N Thiong'o; Grace Mwashigadi; Oscar Chirro; Khamisi Mohamed; Evans Gichuru; John Mwambi; Matt A Price; Susan M Graham; Eduard J Sanders
Journal:  AIDS Behav       Date:  2018-07

6.  Associations Among Perceived HIV Risk, Behavioral Risk and Interest in PrEP Among Black Women in the Southern US.

Authors:  Jessica M Sales; Anandi N Sheth
Journal:  AIDS Behav       Date:  2019-07

7.  External validation of a prediction tool to estimate the risk of human immunodeficiency virus infection amongst men who have sex with men.

Authors:  Qianqian Luo; Xiaojie Huang; Lingling Li; Yingying Ding; Guodong Mi; Sarah Robbins Scott; Yan Zhao; Keming Rou; Na He; Hao Wu; Zunyou Wu
Journal:  Medicine (Baltimore)       Date:  2019-07       Impact factor: 1.817

8.  HIV transmission and pre-exposure prophylaxis in a high risk MSM population: A simulation study of location-based selection of sexual partners.

Authors:  Olivier Robineau; Annie Velter; Francis Barin; Pierre-Yves Boelle
Journal:  PLoS One       Date:  2017-11-30       Impact factor: 3.240

9.  Different guidelines for pre-exposure prophylaxis (PrEP) eligibility estimate HIV risk differently: an incidence study in a cohort of HIV-negative men who have sex with men, Portugal, 2014-2018.

Authors:  Paula Meireles; Michael Plankey; Miguel Rocha; João Brito; Luís Mendão; Henrique Barros
Journal:  Euro Surveill       Date:  2020-07

10.  Acute and early HIV infection screening among men who have sex with men, a systematic review and meta-analysis.

Authors:  Shaun Palmer; Maartje Dijkstra; Johannes Cf Ket; Elizabeth W Wahome; Jeffrey Walimbwa; Evanson Gichuru; Elise M van der Elst; Maarten F Schim van der Loeff; Godelieve J de Bree; Eduard J Sanders
Journal:  J Int AIDS Soc       Date:  2020-10       Impact factor: 5.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.